Your Position:Home>Products>Monoclonals/Polyclonals>Cabiralizumab ELISA Kit

Cabiralizumab ELISA Kit

  • Cat. No.:RB9TDY035018
  • Price:Negotiable
  • Clicks:390

Product Detail

Product Parameters

ApplicationsELISA
Detection MethodColorimetric
Sensitivity0.156 μg/ml
Detection Range0.31-5 μg/mL
Recovery80-120%
Sample TypePlasma, Serum
Assay TypeQuantitative
Stability and StorageThe stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Shipping Condition2-8 ℃
Accession NumberP07333
BackgroundCabiralizumab (FPA008) is a humanized monoclonal antibody directed against colony stimulating factor-1 receptor (CSF1R), which is a member of the CSF1/PDGF receptor family of tyrosine-protein kinases. The developers of cabiralizumab including Apexigen, Bristol-Myers Squibb, Five Prime Therapeutics, University of Chicago and Yale University. Although it is reported to be designed for the treatment of tenosynovial giant cell tumor, the studies of treatment for pancreatic cancer, pigmented villonodular synovitis, malignant melanoma, non-small cell lung cancer, renal cell carcinoma and solid tumors also have been reported to be undergoing. The trails of pancreatic cancer and pigmented villonodular synovitis are in Phase II, while others are in Phase I. Orphan designation of cabiralizumab had been granted in the United States and European Commission for the treatment of pigmented villonodular synovitis.
Alternative NamesFPA-008, , 1613144-80-1
NoteFor Research Use Only.
For Research Use Only. Not for Diagnostic Procedures.

Related Products:
Total 33055 records,Divided into 1653 pages,The 1 pages | First Prev Next Last
Live Chat
  • Tel:
  • WeChat ID: 15898894496
  • Add Message
  • 9:00 AM – 6:00 PM